According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โน3.46 Billion a decrease over its 2022 earnings that were of -โน3.26 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.